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Introduction
Since ultrasound imaging technology first pro-
vided an insight into the human heart, our diag-
nostic capabilities have increased exponentially as a
result of growing knowledge and developing tech-
nology. Significant advances in the ultrasound imag-
ing area, such as the transition from M-mode to
2-dimensional (2D) imaging, coupled with the addi-
tion of pulsed- and continuous-wave Doppler and
color flow imaging, have established echocardiog-
raphy as one of the most frequently used clinical
diagnostic tools. In daily cardiology practice, evalua-
tion of left ventricular (LV) size and function is by far
the most common purpose for performing echocar-
diography. Important diagnostic, prognostic, and
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The principal application of echocardiography is to provide a noninvasive and cost-effective
method to answer the clinical questions about cardiac morphology and function, which
may have impacts on the treatment strategy for many clinical conditions. However, due to
inevitable geometric assumptions in assessing the morphology of the left ventricle (LV),
both M-mode and two-dimensional echocardiography are suffering from inaccuracy in the
measurements and drawbacks of conspicuous inter- and intraobserver variability. Although
time-consuming and difficult in reconstruction, three-dimensional (3D) echocardiography
was developed years ago to partly address these limitations. Previously, 3D echocardio-
graphic images were marginal in quality and the acquisition was cumbersome. In recent
years, as a result of the advances in computer processing and transducer construction tech-
niques, a quantum leap in 3D imaging means that real-time transthoracic 3D echocardio-
graphy is now available from certain major ultrasound system manufacturers. Software
programs to analyze the 3D datasets of LV are also readily on hand. The combination of
new instrumentation and software has been shown to provide highly accurate analysis of
LV morphology and function compared with cardiac magnetic resonance such that this
methodology is likely to ensure echocardiography as the first-choice technique for non-
invasive evaluation of LV.
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treatment decisions rely upon analysis of LV changes.
The bedside availability, cost, and noninvasive nature
of echocardiography has destined this technique as
the method of choice for performing the analysis.
Significant advances in ultrasound, electronic,
and computer technologies have provided a thrust
toward the development of a fully sampled matrix
array transducer and online 3-dimensional (3D)
display of rendered images, as well as software 
for postprocessing and quantification. Readers are
referred to some recent excellent reviews on the
technical progress and clinical applications of 3D
imaging [1–3]. The introduction of 3D imaging
and its evolution from slow offline reconstruction
to real-time volumetric imaging have brought 3D
echocardiography closer to routine clinical use for
the ease of data acquisition, the ability to image an
entire heart nearly in real time, as well as the apti-
tude to focus on a specific structure in a single beat.
The major proven advantage of this technique is the
improvement in accuracy for evaluating the cardiac
chamber volumes, which is achieved by eliminating
the need for geometric assumptions and the errors
caused by foreshortened views. Another benefit of
3D imaging is the realistic and unique comprehen-
sive view of cardiac valves and congenital abnormal-
ities. In addition, 3D imaging is enormously useful in
the intraoperative setting because it allows immedi-
ate feedback on the effectiveness of interventions.
Within years of its inception, real-time 3D (RT3D)
technology has sparked new actions in investiga-
tion and given an indication into the future of
echocardiography.
Advantages in Quantification by RT3D
Echocardiography Technology
Three-dimensional echocardiography has shown its
clinical advantages since the early 1990s. The bene-
fits of 3D echo in clinical decision-making are both
qualitative and quantitative. One of the key facts is
that 3D echocardiography provides the opportunity
to view the heart from any perspective and to view
structures from the surgeon’s viewpoint, having
better feedback of abnormalities and relative ana-
tomy of structures or defects. The possibility for
image display and orientation is limited only by the
imagination. The qualitative benefits from 3D imag-
ing include: (1) more effective and descriptive com-
munication between imaging specialists and other
medical staff; (2) better appreciation of the posi-
tion of defects in relation to other cardiac structures
(Fig. 1); (3) accurate description of valve character-
istics in planning for surgical repair with live assess-
ment of valve functional dynamics; and (4) precise
visualization during invasive procedures such as
transcatheter occlusion of atrial septal defect. Pro-
viding unique realistic views of cardiac valves and
congenital abnormalities, 3D echocardiography is
extremely helpful for showing a variety of patho-
logies and assessing the effectiveness of surgical or
percutaneous transcatheter interventions.
In terms of the clinically accessible quantification,
there are two current approaches to 3D echocardio-
graphy, which have replaced the previously used
time-consuming and stable heart rate-requiring
reconstruction method that obtained 3D imaging
from a set of 2D planes by either rotating or tilting
the conventional 2D transducer. The first approach
is RT3D echocardiography, which uses an array 
of crystals to direct ultrasound anywhere within 
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Fig. 1. Aneurysm of sinus valsalva. Real-time three-dimensional
echocardiography shows an aneurysm (arrow) that originated
from the right coronary cusp and extended into the right ven-
tricular outflow tract (RVOT), with the anatomic relationship
to the left ventricle (LV) and atrium (LA). In this case, there
was an associated subaortic ventricular septal defect.
a pyramid of space. Despite parallel processing (typ-
ically ∼16:1), this often requires combining data
from 3 to 5 cardiac cycles to obtain a full 90° × 90°
3D pyramid dataset. This technique is based on the
live 3D echocardiography comprising the weakness
of temporal resolution of about only 15–20 frames
per cardiac cycle. Secondly, a full 3D echocardio-
graphy can be obtained from transducers capable
of simultaneously acquiring up to three rotationally
arranged planes, simulating the total LV by geo-
metric modeling with the higher temporal resolu-
tion and quantitative accuracy to some extent, but
unavoidably, with a limited spatial resolution. An
important technical issue involves the number of
slices from which the ventricular volume (or mass)
is measured, ranging from 2 [4] to 12 [5], with falling
accuracy when the number of planes is < 4 [6]. The
argument against too many slices is the time and
effort required for analysis. Fortunately, software is
emerging that can automatically detect endocar-
dial borders during a cardiac cycle [7]. The rapid
evolution of these novel technologies and the
absence of a comprehensive industry-wide format to
store the data allowing more options in postpro-
cessing and visualization, hinder the consensus on
when to perform 3D echocardiography in clinical
practice, although the American Society of Echocar-
diography is soon to release a guidelines document
[8]. The Digital Imaging and Communications in
Medicine committee is pursuing such a standard,
but progress has been slow.
Recent investigations have shown the promising
advantages of 3D echocardiography in quantifica-
tion. The most important advantage is in directly
evaluating the cardiac chamber volumes without
the need for geometric modeling and the unfavor-
able effects of foreshortened views. After incorpo-
rating the Doppler information, 3D color imaging
affords the volumetric quantification of regurgitant
lesions (Fig. 2), shunts, and cardiac output. With the
help from myocardial contrast agents, 3D echocar-
diography is also applied to volumetric quantifica-
tion of myocardial perfusion. Recent investigations
have tested the feasibility of real-time 3D echocar-
diographic perfusion imaging and validated an
algorithm for volumetric analysis of myocardial con-
trast inflow in an ex vivo model of controlled global
coronary flow, an in vivo model during regional
perfusion variations, and humans during pharmaco-
logically induced hyperemia [9]. In some instances,
the scientific evidence seems strong enough to
endorse the use of 3D echocardiography as a new
standard in the clinical assessment of the heart
[10–14].
The principal advantage in quantification is the
direct and assumption-free analysis of LV mass and
volume with the possibility to accurately assess
volumes for other cardiac chambers. Directly com-
paring the accuracy and reproducibility in measur-
ing LV volumes and ejection fraction (EF), almost all
studies have shown the superiority of the 3D
approach over the 2D methodology, which was
shown to consistently underestimate LV volumes.
This superiority was also shown when compared
against independent reference techniques, such as
radionuclide ventriculography or magnetic reso-
nance imaging (MRI) [5,15,16]. Although in earlier
3D studies, quantification of LV size and function
relied on monotonous, manual, or at best semiau-
tomated tracing of endocardial boundaries in multi-
ple planes, today it is based on near fully automated
frame-by-frame detection of the 3D endocardial
surface from RT3D data sets. Recently, a similar
approach implemented in commercial imaging
systems is rapidly gaining widespread popularity
because of its accuracy and ease of use [11] and is
on the edge to become part of the mainstream
assessment of LV function.
The direct assessment of regional LV wall motion
from the 3D dataset helps to objectively detect
ischemic heart disease at rest or during stress test-
ing. When RT3D echocardiography was compared
with 2D echocardiography under dobutamine stress
for the detection of myocardial ischemia with
angiographic validation, a recent study [17] has
shown that RT3D echocardiography identifies
more readily wall-motion abnormalities in the api-
cal region than 2D approaches, which may explain
the tendency toward higher sensitivity in the left
anterior descending artery territory. The RT3D
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echocardiography has a diagnostic equivalence to
2D echocardiography, with the advantage of sig-
nificant shorter acquisition times.
There are some other advantages to RT3D echo-
cardiography in quantification. The precise meas-
urement of atrial septal defects and anatomic
structural relationships using optimal anatomic
planes will help the interventionists select proper
sizes of occluders and to avoid the barricade of the
related venous or valvular inflow. With an access to
“en-face” view of the complete valve apparatus for
accurate planimetry of stenotic valves by RT3D
echocardiography, Mannaerts et al [14] has recom-
mended 3D echo as the gold standard to measure
mitral valve area particularly during interventions
such as balloon valvuloplasty which cause hemo-
dynamic changes to render other methods such as
pressure half time inaccurate. The RT3D echocar-
diography, capable of analyzing the mitral annular
dynamics and deformation throughout the heart
cycle, can help to understand the geometric mecha-
nism and remodeling for functional ischemic mitral
regurgitation (FIMR). Watanabe et al [18] have
clearly demonstrated 3D geometric deformity of
the mitral leaflets and annulus in FIMR using novel
software for creating images by 3D echocardiogra-
phy. This technique is considered helpful in making
a proper decision for the surgical strategy in each
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Fig. 2. (A) Three-dimensional (3D) color flow imaging with 3D
color flow jets superimposed on the grayscale data from a patient
depicting a 3D aortic regurgitant jet in diastole. The combination
of 3D color flow with grayscale information shows the origin and
direction of jets, affording the possibility to measure the regurgi-
tant orifice area, and to improve the delineation of valvular
leaks. (B) The grayscale data helps us to describe the degener-
ative aortic valves. (C) The level of the vena contracta (arrow) of
the regurgitant jet is visualized, and its width can be measured
with appropriate projection.
patient and has shown that mitral valve leaflets were
widely tethered toward the left ventricle in anterior
myocardial infarction, in contrast with inferior myo-
cardial infarction showing localized tenting of the
leaflet [19]. They have also found that the mitral
annulus flattens in FIMR, with greater deformity of
the mitral annulus in the anterior rather than in 
the inferior myocardial infarction group [20]. De
Castro et al [21] have developed a ratio between LV
mass and end-diastolic volume (LVRI), detected by
RT3D echocardiography to describe various pat-
terns of LV remodeling. They found that the LVRI
may serve as a simple and useful indicator 
of LV adaptation to physiologic and pathologic
conditions.
The 3D echo may be used to estimate stroke
volume and cardiac output and thereby provide
better quantification of the severity of regurgitant
lesions. The 3D color Doppler also more accurately
represents the true shape of the vena contracta.
Effective regurgitant orifice area is a useful index of
the severity of mitral regurgitation (MR). The cal-
culation of regurgitant orifice area using the pro-
ximal isovelocity surface area (PISA) method has
some technical limitations. The possibility for more
direct assessment of regurgitant flow volumes and
regurgitant orifice using 3D color flow imaging
has been studied by Iwakura et al [22]. They have
found that 3D echocardiography provided robust
values independent of the eccentricity of the MR
jet or of cardiac rhythm. The direct measurement
of the regurgitant orifice area of MR with 3D color
Doppler echocardiography could be a promising
method to overcome the limitations of the PISA
method, especially in cases of MR with elliptic 
orifice shapes.
However, there are several questions that con-
tinue to hinder the daily use of 3D color Doppler
echocardiography. First of all, the reliance on
acquisition of multiple cardiac cycles may cause
stitch artifacts because the patient cannot maintain
a breathhold over 7–10 beats. Second, inadequate
sector angle may hamper complete visualization of
eccentric jets. Third, the visualization of 3D grayscale
dataset acquired simultaneously will compromise
the information from color Doppler imaging. Single-
beat acquisition with wider sector and improved
resolution as well as online quantification tools are
the issues that need to be addressed for 3D color
flow imaging to become clinically useful [2].
Regional LV Function
Echocardiography is the most widely used imaging
modality for the evaluation of global and regional
LV function. Many approaches aimed at quantita-
tive analysis of dynamic images based on manual or
semiautomatic tracing of endocardial boundaries
to reduce the reliance on the reader’s experience
and ability to integrate spatial and temporal infor-
mation, such as acoustic quantification and color
kinesis, have not gained widespread clinical use. Both
visual interpretation and quantitative analysis of 2D
images use only partial information about cardiac
anatomy and function contained in specific cross-
sectional planes. It is likely that direct 3D quantifi-
cation of the displacement of endocardial surface
segments could aid in accurate determination of the
extent of wall motion abnormalities. Corsi et al [7]
have developed a technique that could be applied
to RT3D echocardiographic data sets throughout
the cardiac cycle and lead to an alternative approach
for fast, easy, and objective dynamic quantification
of global and regional LV function without the need
for either plane selection or geometric modeling.
After being validated against cardiac MRI on a global
and regional basis, this approach has been shown
to accurately evaluate not only the magnitude but
also the temporal aspects of LV function, allowing
one to create new opportunities for objective detec-
tion of wall motion abnormalities, to quantify LV sys-
tolic asynchrony, and to assess regional LV diastolic
properties. A recent study by Nesser et al [23] has
also shown that the analysis of RT3D echocardio-
graphic data provides accurate quantification of
regional LV function and allows semiautomated
detection of regional wall motion abnormalities,
which is as accurate as the same algorithm applied
to cardiac magnetic resonance images.
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Fig. 3. Assessment of left ventricular (LV) asynchrony by real-time three-dimensional (RT3D) echocardiography. (A) The demonstra-
tion of LV volume in late systole is produced by semiautomatic tracings of endocardial border in the 3D voxel (the term used in
RT3D corresponding to what “pixel” means for 2-dimensional [2D] imaging). The mesh represents the endocardial border in end
diastole. Segments are marked with different colors with corresponding comparisons of differences (Dif) and dispersions (standard
deviation, SD) in time to minimal systolic volume (Tmsv) shown. (B) The 3D segmental time-volume curves for this heart with nor-
mal synchronicity is shown with few dispersions (white arrowhead) in Tmsv (indicated by red triangles for each segment) after normal-
ization. (C) The 3D time-volume curve data can also be used to generate two new parametric imaging modes. The first (lower part of
panel C) allows bull’s eye representation of wall excursion whereby dark areas represent reduced excursion and bright blue areas are
those that exhibit the largest systolic radial excursion. This excursion data may then be used to produce a parametric display (upper
part of panel C) based on timing of contraction. In this instance, green areas represent areas that are synchronous, blue areas contract
early and red/yellow areas show late contraction. This normal heart showed good synchronicity and satisfactory endocardial excur-
sion. (D) For another case with anterior myocardial infarction, the apical akinesia is shown by the multiple sliced 2D imaging and the
delayed Tmsv(s) for apical segments (white arrows). (E) The parametric imaging modes show delayed (red color in upper bull’s eye rep-
resentation) and akinetic/dyskinetic (dark/red colors in lower bull’s eye representation) motions of the apical region.
The volumetric analysis by RT3D echocardiog-
raphy is a full surface-rendering method using all
voxel data (Fig. 3A). With advanced parallel process-
ing and breakthrough software design technology,
the tremendous increases in computational speed
allow rapid generation of a full 3D wire-mesh endo-
cardial volume with minimal operator intervention.
Advanced physics-based modeling plus 3D pattern
matching, tracking the mitral annulus and apex over
time, provides an “active object” motion presenta-
tion of the dynamic 3D shape. This allows 3D borders
for the endocardial space in each frame to be com-
bined into a smooth beating volume with highly
accurate spatial and temporal motion detail. The
construction of high-resolution RT3D data illustrate
changes in regional myocardial motion and LV con-
traction patterns in an exact and quantitative way,
showing a segmental volume-time curve (Fig. 3B) as
a methodology to assess LV asynchrony comparable
with tissue Doppler imaging [24] and select suitable
candidates for cardiac resynchronization therapy
(CRT, see later) with a favorable response [25].
Parametric Imaging: Mapping the
Excursion Amount and Peaking Time
The RT3D data for LV function are quantitative, and
can be displayed as curves (volume-time curves) or
numbers. Quantitative analysis in all segments of
the LV, however, is time-consuming. Color display,
or parametric imaging, reduce the displayed data to
semiquantitative information, allowing a quick visual
assessment of functional data over a larger area. In
addition, this display allows new measurements,
such as area and proportion of asynchrony.
Three-dimensional time-volume curve data can
also be used to generate two new parametric
imaging modes (Fig. 3C). The first (Fig. 3C, lower)
allows a bull’s eye representation of wall excursion
whereby dark areas represent reduced excursion
and bright blue areas are those that exhibit the
largest systolic radial excursion. On the contrary,
the red areas represent the dyskinesia. This excur-
sion data may then be used to produce a paramet-
ric display based on timing of contraction (Fig. 3C,
upper). In this instance, green areas represent
areas that are synchronous, blue areas contract
early, and red/yellow areas show late contraction. It
is possible to set an excursion threshold for the tim-
ing display in order to suppress data from areas
such as the apex that do not contribute sufficiently
to contractile performance.
New evidence is emerging that mechanical
intraventricular dyssynchrony provides a potential
independent predictor of patient response [25]. This
mechanical evidence can be readily obtained by
determining the time to obtain minimum systolic
volume (Tmsv) for each segmental waveform and
analyzing the dispersion in these values. The wider
the dispersion or standard deviation of Tmsv values,
the greater is the degree of mechanical dyssynch-
rony. The standard deviation of Tmsv values, the
dispersion of time to obtain minimum regional
volume for all 16 LV segments, has been referred
to as the systolic dyssynchrony index (SDI) [26].
3D evaluation of segmental timing and function
can therefore offer a valuable tool in the selection,
optimization, and monitoring of patients under-
going CRT (Fig. 4).
Dyssynchrony Analysis and Cardiac
Resynchronization Therapy
CRT has become a therapeutic option in symp-
tomatic heart failure, shown in randomized trials
to decrease hospitalizations and mortality, to im-
prove hemodynamics and exercise tolerance in
symptomatic patients with reduced EF and a QRS
width of 120 ms or more [27,28]. In initial studies,
the width of the QRS complex has been consid-
ered as a surrogate for cardiac mechanical asyn-
chrony. However, following current strategy to
identify candidates, about a quarter of patients
treated by CRT will lack improvement (‘’nonres-
ponders’’). Alternatively, significant LV mechanical
asynchrony has been acknowledged in patients
with heart failure and normal QRS duration, sug-
gesting that some of these patients might re-
spond to CRT [29,30]. The proportion of heart
failure patients who might benefit but who are not 
covered by current indications is unknown. To opti-
mize the application of this costly therapy, echocar-
diography is a particularly promising technique to
directly evaluate mechanical (as opposed to elec-
trical) asynchrony with high temporal and spatial
resolution.
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Conceptually, cardiac asynchrony can be divided
into atrioventricular, interventricular, and intraven-
tricular asynchrony of the left ventricle [31]. Intra-
ventricular asynchrony appears to be the most
important factor for the success of CRT. The princi-
ple of determining intraventricular asynchrony for
CRT is to identify the longest regional delay in
mechanical activity and to realign it with the rest
of the ventricle by pacing. Initially, asynchrony was
assessed by M-mode echocardiography that deter-
mined the delay of contraction between the an-
teroseptal wall and posterior wall, and a cutoff of
130 ms was found to be predictive of CRT benefit.
Several newer approaches have been proposed and
examined in recent years. Tissue Doppler, which
measures tissue motion velocity, and its derived
modality, deformation imaging, which measures
regional strain and strain rate, are able to determine
timing and extent of LV mechanical events with
good spatial and very high temporal resolution.
While initial studies have used pulsed tissue Doppler,
acquisition of color-coded maps of tissue velocities
is faster and more convenient, since the velocity
information from different segments and walls can
be recorded in the same cine loop.
The standard deviation of the time from onset
of QRS to peak systolic tissue velocity of the basal
and mid segments of all six LV walls has been shown
to predict mechanical benefit from CRT with a cut-
off of 33 ms. In a recently published head-to-head
comparison of the predictive power of several tissue
Doppler parameters, this parameter (TDI Asynchrony
Index) had the best predictive power [32]. This
approach has been taken further by automatically
color coding segments according to their time to
peak systolic tissue velocity (‘’tissue synchronization
imaging’’ and similar parametric imaging modali-
ties from different manufacturers) for easier detec-
tion. A similar, but simplified approach using only
the difference in time to peak between the basal
septum and basal lateral wall segment in the apical
four-chamber view has also been used recently. A
septal to lateral delay of 65 ms or more in time to
peak tissue velocity predicted improvement in LVEF
and clinical symptoms [33,34].
However, it should be recognized that a fun-
damental methodologic limitation of Doppler meth-
ods is being prone to angle-related errors for velocity
and, even more, strain and strain rate. Most re-
searchers have therefore only assessed longitudinal
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Fig. 4. Improvement of left ventricular asynchrony by cardiac resynchronization therapy (CRT). The parametric imaging (upper
panels) and regional filling curves (lower panels) are derived from a patient with severe asynchrony and heart failure before CRT
(Pre-CRT, A). There is wide variation in the timing of regional minimal volume with corresponding presentation in the parametric
imaging mode. After institution of CRT, mechanical synchrony is improved (Post-CRT, B).
velocities. Second, the tissue synchronization imag-
ing and similar color-coding algorithms are very sen-
sitive to the settings of the time window within which
the algorithm searches for the peak positive tissue
velocity. This window defaults to an interval derived
from the ECG signal, which may or may not accu-
rately represent LV ejection. Its use should there-
fore always be checked against the actual timing
of valvular events, in particular aortic valve closure.
Third, tissue Doppler-based methods are operator
dependent and fail to provide rapid concomitant
assessment of global volume and EF. Fourth, nei-
ther tissue velocity imaging nor strain/strain rate
imaging can distinguish active from passive motion
(for example, active shortening from passive recoil
after previous stretching). Thus, areas of ‘’delayed
contraction’’ may simply represent scar tissue and
not contain contractile myocardium, and thus not
benefit from CRT. Furthermore, theoretically not
only the timing of tissue velocities matters but also
the actual extent of tissue displacement, because
this displacement corresponds to the amount of
blood propelled and thus to mechanical efficiency.
This displacement is not only related to the timing
of peak velocity, but also to the integral of tissue
velocities and to the amount of tissue participating
in this motion. A small LV region with a late peak in
systolic tissue velocity should not be considered to
have a similar impact on overall ejection efficiency
as a larger dyskinetic region just for the same delay
in time to peak systolic velocity.
Another newer technique, mentioned earlier, is
to evaluate the timing of regional LV inward
motion of endocardium by RT3D echocardiogra-
phy [26]. With the use of a semiautomated endo-
cardial boundary recognition algorithm, regional
filling curves are derived for LV myocardial seg-
ments, and the timing of these curves is compared
with visualized ventricular asynchrony. Therefore,
RT3D echocardiography offers an approach which
combines accurate determination of delayed con-
traction sites and mechanical dyssynchrony
together with global LV function data. It takes all
myocardial segments into account, by examining
the composite effect of radial, circumferential, and
longitudinal contraction on volumetric data. The
generation of time-volume curves representing LV
volume changes over the heart cycle is feasible
and accurate and allows calculation of indices such
as the SDI for detailed quantitative analysis of LV
performance. A higher SDI denotes increasing intra-
ventricular dyssynchrony and possible benefit after
CRT. With help from parametric imaging, the delay
and impairment of endocardial excursion could be
compared with the global ventricular event. It can
direct clinicians to select proper patients for CRT
and avoid pacing on the nonfunctional (scar) myo-
cardium after distinguishing between the active
(with sufficient endocardial excursion) and passive
(with limited endocardial excursion) motion.
We are currently witnessing the advent of new
diagnostic tools and therapies for heart diseases,
but without serious scientific consensus on funda-
mental questions about normal and diseased heart
structure and function. During the last decade, three
successive, international, multidisciplinary symposia
were organized in order to set up fundamental
research principles, which would allow us to make
a significant step forward in understanding heart
structure and function [35]. Helical ventricular
myocardial band of Torrent-Guasp is a revolutionary
new concept in understanding global, 3D, func-
tional architecture of the ventricular myocardium.
This concept defines the principal, cumulative vec-
tors, integrating the tissue architecture (i.e. form)
and net forces developed (i.e. function) within the
ventricular mass of the heart. When we perform
RT3D echocardiography, this model helps us to real-
ize the contractile mechanics and integrate the infor-
mation by other echocardiographic techniques.
Within the ventricular mass, size, shape, connec-
tions and orientation in a 3D space of every single
constituent determine its functional behavior. This
kind of spatial dependence allows the ventricular
myocardial mass to be considered as the source 
of interdependent vectorial forces (i.e. electrical
and mechanical), being generated on different
length and time scales [36]. The ultimate net result
of these vectorial forces is to translate uniaxial sar-
comere shortening into efficient 3D deformation
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of the ventricular cavity. The complex architecture
of the ventricular mass creates multiple inhomo-
geneities of electrical and mechanical loads at the
cellular and microscopic tissue level that cause car-
diac function to be “stochastic in nature”. However,
at the macroscopic (i.e. organ) level, these stochas-
tic events become average and appear consistent
with a continuous medium. This dialectic coexis-
tence of complexity and simplicity, discreetness, and
continuity suggests the existence of certain rule-
based assignment, which “may be applied equally
well to all the ventricular myocardial fibers”, enabling
the ventricular myocardial mass to assemble abun-
dant, dynamic, stochastic vectorial forces and pro-
duce apparently smooth, averaged, continuous,
global response.
The unique 3D organization of myocardial fibers
of the mammalian ventricle comprises not only cir-
cumferential fibers and longitudinal fibers but also
obliquely running fibers that form a helical spiral
from base to apex. When viewed from the apex of
the LV, the orientation of fibers changes smoothly
from left-handed helical fiber in the subepicardium
to circumferential fiber in the mid wall to right-
handed helical fiber in the subendocardium. This
structure is a key determinant of ventricular mechani-
cal properties, including torsion, strain, and stress,
and structure adaptation. We recognize that the LV
works with physiologic inhomogeneities to direct
the intraventricular flow with morphodynamic
advantage in conserving the energy of blood flow,
increasing pumping efficiency at accelerated heart
rates [36]. Therefore, the prospective investigation
of LV should involve measurements in three aspects:
(1) the force or strain of local myocardium that
could be assessed by tissue Doppler or 2D speck
tracking imaging in multidimension; (2) the alter-
ations in shape and volume of regional LV cavity that
are generated by the corresponding displacement
of local myocardium and should be viewed in
RT3D; (3) the intraventricular flow field and pump-
ing efficiency influenced by the LV geometry. RT3D
echocardiography is one of the vital tools for fur-
ther delineating the relationship between the form
and function of LV.
Conclusion
Advances in echocardiographic instrument techno-
logy and computer processing power, such as the
ease of data acquisition, the ability to image the
entire heart nearly in real time, as well as the ability
to focus on a specific structure in a single beat
have brought 3D echocardiography from being a
time-consuming research tool to a clinically pre-
vailing and applicable procedure. Presently, there
is sufficient evidence to prove that 3D imaging is
superior to the traditional 2D techniques and should
be routinely used in at least two clinical scenarios.
First, using RT3D echocardiography for the quan-
tification of LV volume, EF and mass can provide
answers to the most commonly asked question from
any cardiac imaging methodology — what is the
LV function? Second, RT3D echocardiography
should be used for quantification of the mitral valve
area in mitral stenosis. We anticipate that, in the
coming years, RT3D imaging will continue to be
integrated into some routine echocardiographic
examinations, including stress testing with real-
time volumetric or simultaneous multiplane imaging
from a single transducer position, the visualization
and dimensional measurements of septal defects,
and the complete geometric and hemodynamic
evaluation of valves. Volumetric assessment of ven-
tricular asynchrony will be used as an additional tool
to guide resynchronization therapy.
Also, miniaturization of matrix-array transducer
technology will enable both the acquisition of RT3D
transesophageal images and the development of
small-footprint probes suitable for pediatric trans-
thoracic and fetal imaging. 3D echocardiography
has now been shown to have several advantages
over 2D echocardiography, particularly for volume
measurements, visualization of septal defects, and
whole-valve evaluation. Given these data, it is clear
that 3D echocardiographic imaging will soon be-
come a standard imaging modality for all new echo
systems and a part of routine echocardiographic
examinations. In the future, it will seem unaccept-
able to perform an echocardiographic study with-
out using 3D to analyze global and regional LV
L.C. Lin, C.S. Liau, Y.T. Lee
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function as it is now to perform conventional 2D
echocardiographic study without the use of Doppler.
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